This page keeps track of new/upcoming treatment options for systemic lupus erythematosus (SLE). What’s in development? What’s promising? What’s available soon? Find out below… Current topics include PRV-3279, IL-2, RSLV-132, tolDCs, lysosomes, PRV-3279, immunoproteasome inhibitors, KZR-616, BMS-986165, and more.
Last updated: 4 years ago
Subscribe
News
- American College of Rheumatology Secures $7M Grant to Address Gaps in Lupus Care and Treatment Sep 21, 2020
- New Research Identifies Potential Treatment for Nervous System Dysfunction in Lupus Patients Mar 18, 2020
- Provention Announces Positive Data from Phase 1b Study of PRV-3279, which has the potential to intercept the pathophysiology of systemic lupus erythematosus (SLE) Mar 12, 2020
- IL-2 Treatment Passes Safety Trial for Systemic Lupus Sep 10, 2019
- Anifrolumab Phase III trial meets primary endpoint in systemic lupus erythematosus Aug 29, 2019
- Provention Bio Initiates Phase 1b/2a PREVAIL Clinical Trial Evaluating PRV-3279 in Lupus Aug 8, 2019
- Resolve Therapeutics Announces Completion of Enrollment for Phase 2a Study of RSLV-132 for the Treatment of Lupus Jul 22, 2019
- Quercetin is a potential therapeutic drug for lupus nephritis (LN) Jul 18, 2019
- New research offers hints to origins of systemic lupus erythematosus Jul 4, 2019
- Chinese Nobel laureate ‘cautiously optimistic’ about progress towards lupus treatment [artemisinin] Jun 28, 2019
- Lupus treatments can be tailored to patient’s individual cells, study shows May 20, 2019
- Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date May 7, 2019
- Chinese scientists have found that a lack of circular RNAs may spin the immune system out of control and lead to lupus May 4, 2019
- A new grant will allow Michigan Medicine researchers to explore personalized approaches to treating autoimmune diseases such as lupus May 1, 2019
- FDA approves first treatment for pediatric patients with lupus Apr 26, 2019
- Study on Xeljanz Suggests Drug is Helpful for People with Lupus Apr 25, 2019
- Phase 2 clinical trial of BMS-986165 in patients with Systemic Lupus Erythematosus (SLE) is now recruiting Apr 18, 2019
- Exciting Research News from 13th International Congress on Lupus Apr 12, 2019
- Aptevo Therapeutics Begins Phase 1 Clinical Trial of APVO210 a Novel Bispecific Antibody for the Treatment of Autoimmune and Inflammatory Diseases Apr 4, 2019
- Researchers developing early detection, home monitoring tests for lupus nephritis Apr 2, 2019
- Kezar Life Sciences Announces Presentations at Upcoming Scientific Conferences – “Furthermore, at Lupus 2019, we will present some compelling gene expression data for KZR-616, our novel immunoproteasome inhibitor” Mar 28, 2019
- Restoring this enzyme’s function protects against heart disease in lupus and beyond – “restoring endothelial function deserves further study as an additional therapeutic approach for patients with lupus” Mar 25, 2019
- Aptevo Therapeutics Begins Phase 1 Clinical Trial of APVO210 a Novel Bispecific Antibody for the Treatment of Autoimmune and Inflammatory Diseases (including lupus) Mar 20, 2019
- Study Evaluates Two Drug Therapies on Children with Lupus Nephritis Mar 18, 2019
- Reducing B cells with CAR T cells is effective treatment of experimental lupus Mar 6, 2019
- A CAR-T approach to lupus Mar 6, 2019
- Genetically engineered immune cells wipe out lupus in mice Mar 6, 2019
- Lupus Therapeutics partners with Takeda on phase 1 trial to evaluate TAK-079 as potential new therapy for lupus Mar 1, 2019
- Positive Early Results for BIIB059 as New Treatment Strategy Feb 28, 2019
- Equillium Announces Plan to Develop EQ001 for the Treatment of Lupus Nephritis Feb 26, 2019
- Exagen and the Lupus Foundation of America Partner on New Initiative to Reduce the Time to an Accurate Lupus Diagnosis Feb 26, 2019
- Bacteria in the Gut May be a Cause of Lupus, Shows Study Supported by Lupus Research Alliance Feb 19, 2019
- Lupus strongly linked to imbalances in gut microbiome Feb 19, 2019
- Potential drug therapies persist amid ‘lupus trial graveyard’ Feb 15, 2019
- IFM Therapeutics launches new spinout aimed at Parkinson’s, lupus and other diseases Feb 11, 2019
- Researchers reveal how receptor TLR-9 protects against lupus Feb 4, 2019
- Neovacs to host KOL Meeting to discuss its therapeutic vaccine IFNalpha Kinoid for lupus treatment – February 11th Paris Feb 4, 2019
- ‘Rogue’ clones linked to Lupus disease Jan 28, 2019
- Rituxan Fails to Treat Moderate to Severe SLE without Kidney Involvement, Trial Reanalysis Confirms Jan 25, 2019
- Flinders team claims breakthrough in Lupus research Jan 16, 2019
- IFNalpha Kinoid Continues to be Studied for Treatment of Systemic Lupus Erythematosus Jan 15, 2019
- Approved Asthma Therapy Omalizumab Reduces SLE Disease Activity, Phase 1b Trial Finds Jan 14, 2019
- Asthma Drug Explored in SLE Jan 14, 2019
- Lupus Research Alliance Announces Translational Research Grants to Speed Development of New Treatments Jan 10, 2019
- Idorsia initiates a multiple-dose efficacy and safety study with cenerimod for the treatment of systemic lupus erythematosus Jan 7, 2019
- FDA Grants Fast Track Status to Drug Being Studied for Lupus Treatment Dec 15, 2018
- FDA grants fast track status to baricitinib development for SLE Dec 13, 2018
- Neovacs and Centurion Pharma continue their collaboration in Lupus based on the results of the Phase IIb trial with IFNalpha Kinoid Dec 11, 2018
- Potential New Lupus Treatment Outperforms Hydroxychloroquine in Animal Study Nov 28, 2018
- Stem Cell Treatment Seen to Benefit Lupus Patients in Phase 1 Trial, New Study Opening Nov 12, 2018
- Scientific and Technology Breakthroughs Show Promise for Lupus and Other Immunologic Diseases Jul 16, 2018
- Injectible drug shown to be effective against lupus in clinical trial Apr 20, 2018
- Lupus treatment generates positive results in Phase III clinical trial Apr 20, 2018
Research
- Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus Sep 17, 2020
- Myeloid-derived suppressor cells shift Th17/Treg ratio and promote systemic lupus erythematosus progression through arginase-1/miR-322-5p/TGF-β pathway Aug 18, 2020
- Harnessing SLE Autoantibodies for Intracellular Delivery of Biologic Therapeutics Aug 14, 2020
- LncRNA GAS5 supresses CD4+ T cell activation by upregulating E4BP4 via inhibiting miR-92a-3p in systemic lupus erythematosus Aug 8, 2020
- Dendritic cells’ characteristics in patients with treated systemic lupus erythematosus Jul 30, 2020
- Targeting the Protective Arm of the Renin-Angiotensin System to Reduce Systemic Lupus Erythematosus Related Pathologies in MRL-lpr Mice Jul 23, 2020
- Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review Jul 22, 2020
- B Cell Therapy in Systemic Lupus Erythematosus: From Rationale to Clinical Practice Jul 9, 2020
- Gut microbiota dysbiosis and altered tryptophan metabolism may contribute to autoimmune activation in systemic lupus erythematosus (SLE) Jul 8, 2020
- Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development: miR-7 as a potential treatment strategy in SLE Mar 19, 2020
- Lupus autoantibodies act as positive allosteric modulators at GluN2A-containing NMDA receptors and impair spatial memory Mar 16, 2020
- The Inhibitory Effects of Pentacyclic Triterpenes from Loquat Leaf against Th17 Differentiation: potential application in SLE therapy Dec 4, 2019
- Therapeutic potential of aryl hydrocarbon receptor in autoimmune diseases, including systemic lupus erythematosus (SLE) Oct 15, 2019
- Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus Sep 19, 2019
- Role of anti-DNA auto-antibodies as biomarkers of response to treatment in systemic lupus erythematosus patients: hypes and hopes Sep 13, 2019
- Tolerogenic Dendritic Cell Transfer (tolDC treatment) Ameliorates Systemic Lupus Erythematosus in Mice Sep 11, 2019
- Lysosomes as a therapeutic target in autoimmune disorders – including lupus Sep 2, 2019
- Let-7f-5p ameliorates inflammation by targeting NLRP3 in bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus Aug 14, 2019
- Mechanisms by which MicroRNA-146a (miR-146a) regulate the inflammatory response in systemic lupus erythematosus (SLE) Aug 13, 2019
- Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies Aug 9, 2019
- Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosus Aug 3, 2019
- Targeting AIMP1 could be a novel and highly immune-modulating therapeutic strategy in lupus nephritis Aug 2, 2019
- Autoimmune pathways in mice and humans are blocked by pharmacological stabilization of the TYK2 pseudokinase domain Jul 24, 2019
- MiR-183 injection may serve as an effective therapeutic treatment for delaying or easing pathologic features of systemic lupus erythematosus (SLE) Jul 20, 2019
- Quercetin is a potential therapeutic drug for lupus nephritis (LN) Jul 18, 2019
- Biologics in the Treatment of Lupus Erythematosus: A Critical Literature Review Jul 18, 2019
- Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement—A new target for lupus treatment Jul 10, 2019
- Gas6/TAM Receptors in Systemic Lupus Erythematosus Jul 9, 2019
- Epigenetic programming underpins B cell dysfunction in human SLE Jul 1, 2019
- Therapeutic potential of exosomes in autoimmune diseases such as systemic lupus erythematosdus (SLE) Jun 19, 2019
- Efficacy and Safety of Vitamin D Supplementation in Patients With Systemic Lupus Erythematosus Apr 26, 2019
- Selenium supplementation suppresses immunological and serological features of lupus in B6.Sle1b mice – “could be explored as a potential therapeutic supplement for SLE patients” Apr 22, 2019
- Treatment of murine lupus with TIGIT-Ig – “IGIT-Ig administration showed promising results for both the prevention and treatment of autoimmune diseases in mice.” Apr 18, 2019
- Targeting T Cell Activation and Lupus Autoimmune Phenotypes by Inhibiting Glucose Transporters Apr 17, 2019
- Baricitinib for the treatment of rheumatoid arthritis and systemic lupus erythematosus: a 2019 update Apr 16, 2019
- Therapeutic advances in the treatment of SLE Apr 16, 2019
- Innate Immune Cells’ Contribution to Systemic Lupus Erythematosus – “the groundwork for new therapeutic approaches” Apr 15, 2019
- Treatment Options for Refractory Lupus Nephritis Apr 12, 2019
- Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date Apr 4, 2019
- The central role of nucleic acids in the pathogenesis of systemic lupus erythematosus Apr 3, 2019
- The preliminary efficacy evaluation of the CTLA-4-Ig treatment against Lupus nephritis through in-silico analyses Mar 27, 2019
- Depression and its related parameters increased the production of autoantibodies against 16α-hydroxyestrone-albumin complex in systemic lupus erythematosus. Mar 26, 2019
- IL-17-producing Th17 cells show promise as a target for development of novel therapeutics for systemic lupus erythematosus (SLE) Mar 26, 2019
- Discovery of Branebrutinib (BMS-986195) – Pharmacological inhibition of Bruton’s Tyrosine Kinase (BTK) is anticipated to provide an effective strategy for the clinical treatment of autoimmune diseases such as lupus Mar 20, 2019
- PRKCB enhancement might be a promising strategy to improve macrophage functions in lupus patients with LPS-tolerance from chronic infection Mar 18, 2019
- Novel insights into MSC-EVs therapy for immune diseases including systemic lupus erythematosus (SLE) Mar 18, 2019
- RNA-seq of circular RNAs identified circPTPN22 as a potential new activity indicator in systemic lupus erythematosus Mar 14, 2019
- T helper 17/T helper 1 pathway may represent a novel target for the prevention and treatment of antiphospholipid syndrome in patients with systemic lupus erythematosus Mar 14, 2019
- Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis – “AC is an effective and safe agent in induction therapy of patients with lupus nephritis” Mar 12, 2019
- cGAS activation causes lupus-like autoimmune disorders in a TREX1 mutant mouse model Mar 11, 2019
- Therapeutic Plasma Exchange as Management of Complicated Systemic Lupus Erythematosus and Other Autoimmune Diseases Mar 11, 2019
- Clinical efficacy and safety of rituximab in lupus nephritis Mar 11, 2019
- Triptolide ameliorates lupus via the induction of miR-125a-5p mediating Treg upregulation – “Triptolide treatment reduced disease activity in lupus mice.” Mar 9, 2019
- Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus Mar 6, 2019
- Full high-throughput sequencing analysis of differences in expression profiles of long noncoding RNAs and their mechanisms of action in systemic lupus erythematosus Mar 5, 2019
- Free light chains and chronic autoimmune-based inflammatory diseases Mar 4, 2019
- Protective role of anti-ribosomal P antibody in patients with lupus nephritis Feb 27, 2019
- Potential for cannabinoid receptor 2 (CB2) targeted therapeutics for treatment of inflammatory conditions involving aberrant pDC activity such as systemic lupus erythematosus and rheumatoid arthritis Feb 23, 2019
- Immunological pathogenesis and treatment of systemic lupus erythematosus Feb 22, 2019
- Effect of Anti-BDCA2 mAb Treatment (BIIB059) on pDC IFNα Production From Patients Affected With Cutaneous Lupus Erythematosus Feb 21, 2019
- Clinical Experience of Sirolimus Regarding Efficacy and Safety in Systemic Lupus Erythematosus Feb 21, 2019
- Pim-1 as a therapeutic target in human lupus nephritis – “targeting Pim-1/NFATc1/NLRP3 pathway might be a therapy for human lupus nephritis … mice were used to confirm the therapeutic effects of Pim-1 inhibition” Feb 21, 2019
- Helminth-Based Product and the Microbiome of Mice with Lupus – “This is the first report to demonstrate the effect of a compound derived from helminths on the induction of remission in mice with lupus” Feb 19, 2019
- A promising approach to targeting type 1 IFN in systemic lupus erythematosus Feb 18, 2019
- Development of an ICOSL and BAFF bispecific inhibitor AMG 570 for systemic lupus erythematosus treatment Feb 15, 2019
- B Cells as a Therapeutic Target in Paediatric Rheumatic Disease – “rationale behind the use of B cell-targeted therapies in Juvenile Systemic Lupus Erythematosus (JSLE)” Feb 14, 2019
- Podocytes and autophagy: A potential therapeutic target in lupus nephritis Feb 13, 2019
- Baicalin and ex vivo expanded Foxp3+ regulatory T cells are promising therapeutics for the treatment of lupus Feb 13, 2019
- Defective regulations that emerge from B cells of systemic lupus erythematosus patients can be restored by GA stimulation Feb 11, 2019
- Changing paradigms in the treatment of systemic lupus erythematosus Feb 8, 2019
- Nicotinamide alleviates kidney injury and pregnancy outcomes in lupus-prone MRL/lpr mice treated with lipopolysaccharide Feb 7, 2019
- Curcumin attenuates murine lupus via inhibiting NLRP3 inflammasome Feb 6, 2019
- miR-152 Attenuates the Severity of Lupus Nephritis Through the Downregulation of Macrophage Migration Inhibitory Factor (MIF)-Induced Expression of COL1A1 Feb 6, 2019
- Epigenetically Altered T Cells Contribute to Lupus Flares Feb 5, 2019
- Drug-induced systemic lupus: revisiting the ever-changing spectrum of the disease using the WHO pharmacovigilance database Feb 4, 2019
- Tetra-arsenic tetra-sulfide Ameliorates Lupus Syndromes by Inhibiting IL-17 producing Double Negative T cells Feb 1, 2019
- Reversible SAHH inhibitor protects against glomerulonephritis in lupus-prone mice by downregulating renal α-actinin-4 expression and stabilizing integrin-cytoskeleton linkage Jan 29, 2019
- Apoptotic cell-mimicking gold nanocages loaded with LXR agonist for attenuating the progression of murine systemic lupus erythematosus Jan 23, 2019
- Targeted Treatment of TREX1 Chilblain Lupus and Other Interferonopathies-Taming T REX Jan 23, 2019
- Assessment of Clinical Response to Janus Kinase Inhibition in Patients With Familial Chilblain Lupus and TREX1 Mutation Jan 23, 2019
- PAM3 supports the generation of M2-like macrophages from lupus patient monocytes and improves disease outcome in murine lupus Jan 22, 2019
- Current challenges in the development of new treatments for lupus Jan 17, 2019
- Role of circulating T follicular helper subsets and T follicular helper effector memory cells in systemic lupus erythematosus Jan 15, 2019
- Impact of belimumab on patient-reported outcomes in systemic lupus erythematosus: review of clinical studies Jan 9, 2019
- Gene-function studies in systemic lupus erythematosus Jan 3, 2019
- Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis Oct 5, 2018
- Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets Aug 1, 2018
- Proteomic approaches for novel systemic lupus erythematosus (SLE) drug discovery Jun 4, 2018
- Inhibition of Cyclic GMP‐AMP Synthase Using a Novel Antimalarial Drug Derivative in Trex1‐Deficient Mice May 21, 2018
- Paeoniflorin may be beneficial for the prevention of lung injury in systemic lupus erythematosus May 1, 2018
- Nrf2 as a therapeutic target for rheumatic diseases Apr 13, 2018
- AMG 557 showed safety and potential efficacy in patients with SLE Mar 17, 2018
- A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus Feb 22, 2018
- CXCR4-CXCL12 interaction is important for plasma cell homing and survival in NZB/W mice Feb 10, 2018
- Natural Killer (NK) cells could be an important future therapeutic target for SLE Feb 7, 2018
- New insights into the role of renal resident cells in the pathogenesis of lupus nephritis Jan 12, 2018
Clinical Trials
- Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it’s Association With Disease Activity and Organ Damage Sep 22, 2020
- Efficacy and Safety of Belimumab in SLE Patients Aug 18, 2020
- A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State Jun 30, 2020
- Efficacy and Safety of Low-dose IL-2 in Patients With SLE: a Multicenter, Randomised, Placebo-controlled Trial Sep 4, 2019
- Ramipril, Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosus [Completed] Jun 10, 2019
- Effect of Curcumin on Systemic Lupus Erythematosus May 16, 2019
- A Study of LY3361237 in Participants With Systemic Lupus Erythematosus May 1, 2019
- Long-Term Safety and Efficacy Study of BMS-986165 in Participants With Systemic Lupus Erythematosus Apr 18, 2019
- Mesenchymal Stromal Cells (MSC’s) in Renal Lupus Apr 17, 2019
- Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus Apr 5, 2019
- A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN) Mar 29, 2019
- A Study of KZR-616 in Patients With Systemic Lupus Erythematosus With and Without Nephritis Mar 26, 2019
- Study of IFN-K in Systemic Lupus Erythematosus Mar 21, 2019
- Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus Mar 21, 2019
- Safety of IFNa Kinoid in Systemic Lupus Erythematosus (completed) Mar 21, 2019
- A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE) Mar 19, 2019
- Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE) Mar 18, 2019
- Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain Mar 14, 2019
- Autologous EBV-specific Cytotoxic T Cells for the Treatment of Systemic Lupus Erythematosus (SLE) Mar 12, 2019
- Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus Mar 8, 2019
- A Study to Assess the Safety and Efficacy of Secukinumab in Alleviating Symptoms of Discoid Lupus Erythematosus Mar 7, 2019
- ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE) Mar 5, 2019
- Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus Feb 28, 2019
- A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus Feb 25, 2019
- Safety and Efficacy of Filgotinib and GS-9876 in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE) Feb 21, 2019
- Study to Evaluate BIIB059 in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE) Feb 20, 2019
- A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) Feb 19, 2019
- Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus Feb 15, 2019
- Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis Feb 15, 2019
- An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus Feb 15, 2019
- A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) Feb 15, 2019
- Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE) Feb 11, 2019
- Safety and Efficacy of Filgotinib and GS-9876 in Adults With Lupus Membranous Nephropathy (LMN) Feb 8, 2019
- A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus Feb 6, 2019
- Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients Feb 6, 2019
- Autologous Hematopoietic Stem Cell Transplantation for Refractory Lupus Nephritis Feb 4, 2019
- Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care Jan 30, 2019
- A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus Jan 29, 2019
- A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren’s Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis Jan 25, 2019
- Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis Jan 23, 2019
- An Investigational Study to Evaluate BMS-986165 in Patients With Systemic Lupus Erythematosus Jan 21, 2019
- A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (BRAVE I) Jan 21, 2019
- A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (BRAVE II) Jan 21, 2019
- JBT-101 in Systemic Lupus Erythematosus (SLE) Jan 18, 2019
- Safety and Efficacy of AMG 592 in Subjects With Active Systemic Lupus Erythematosus Jan 17, 2019
- Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE) Jan 16, 2019
- A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus Jan 15, 2019
- BI 705564 in Patients With Systemic Lupus Erythematosus (SLE) Jan 8, 2019
- Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus Dec 28, 2018
